Is it the inflammation or the free radicals that cause ischemia/reperfusion lung injury? (Q48295943)

10 February 2018

title

Is it the inflammation or the free radicals that cause ischemia/reperfusion lung injury? (English)

1 reference

10 February 2018

0 references

Phillip Factor

1

1 reference

10 February 2018

publication date

11 April 2011

1 reference

10 February 2018

published in

Translational Research

1 reference

10 February 2018

volume

158

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

14-16

1 reference

10 February 2018

Apocynin attenuates ischemia-reperfusion lung injury in an isolated and perfused rat lung model

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Pretreatment with edaravone reduces lung mitochondrial damage in an infant rabbit ischemia-reperfusion model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic mouse lung transplants: the pivotal role of vasoactive intestinal peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Intragraft DPP IV Inhibition Attenuates Post-transplant Pulmonary Ischemia/Reperfusion Injury After Extended Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Protection of lung tissue against ischemia/reperfusion injury by preconditioning with inhaled nitric oxide in an in situ pig model of normothermic pulmonary ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

8-Br-cyclic GMP given during reperfusion improves post-transplant lung edema and free radical injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Low-dose carbon monoxide inhalation prevents ischemia/reperfusion injury of transplanted rat lung grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Triptolide inhibits NF-kappaB activation and reduces injury of donor lung induced by ischemia/reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2011.03.004

10.1016/J.TRSL.2011.03.004

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

release_bcexynm3vndylol2m44pyyqc44

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bcexynm3vndylol2m44pyyqc44

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

10 February 2018